A 5-year-old boy from Delhi presents with a 2-year history of progressive bone pain, short stature, and blue-tinged sclera. His mother reports multiple fractures from minor trauma. Serum alkaline phosphatase is elevated. X-rays show generalized osteopenia with thin cortices and multiple healed fractures. Genetic testing reveals a mutation in COL1A1. Which biochemical defect in collagen synthesis best explains the skeletal fragility in this patient?

Explanation

## Clinical Diagnosis: Osteogenesis Imperfecta (OI) Type I ### Patient Presentation **Key Point:** This child has classic features of osteogenesis imperfecta (OI): - Blue sclera (due to thin collagen allowing visualization of underlying choroid vasculature) - Multiple fractures from minimal trauma - Short stature and bone pain - Elevated alkaline phosphatase (reflecting increased bone turnover) - COL1A1 mutation (encodes α1 chain of Type I collagen) ### Type I Collagen Structure and OI Pathogenesis **High-Yield:** Type I collagen has a characteristic **Gly-X-Y tripeptide repeat** where: - **Glycine (Gly)** occupies every third position (1st, 4th, 7th...) - **X and Y** are typically proline and hydroxyproline - Glycine is the only amino acid small enough to fit in the interior of the triple helix ### Why Glycine Substitution Causes OI ```mermaid flowchart TD A[COL1A1 Mutation: Gly → Larger Amino Acid]:::outcome --> B[Steric Clash in Triple Helix Core]:::action B --> C{Structural Consequence}:::decision C -->|Local Distortion| D[Kink in Helix]:::action C -->|Impaired Stability| E[Reduced Tensile Strength]:::action D --> F[Collagen Denaturation]:::action E --> F F --> G[Defective Bone Matrix]:::outcome G --> H[Increased Fracture Risk]:::urgent G --> I[Osteopenia on X-ray]:::outcome ``` **Mnemonic:** **Gly-X-Y = Glycine Every Third** (the core structural requirement of collagen triple helix) ### Collagen Synthesis Pathway and OI Defects | Step | Process | Defect in OI | Result | |---|---|---|---| | **1. Transcription** | COL1A1/COL1A2 mRNA synthesis | Null mutations (Type II OI) | Reduced collagen production | | **2. Translation** | Synthesis of pro-α chains | **Gly substitution (Type I OI)** | **Abnormal triple helix formation** | | **3. Hydroxylation** | Prolyl and lysyl hydroxylase (requires Vitamin C, Fe²⁺, α-ketoglutarate) | Vitamin C deficiency (scurvy) | Defective cross-linking, not OI | | **4. Glycosylation** | Addition of glucose/galactose to hydroxylysine | Rare mutations | Impaired secretion | | **5. Triple Helix Formation** | Collagen chains wind into triple helix | **Gly substitution prevents helix** | **OI Type I** | | **6. Secretion** | Procollagen transported via ER/Golgi | Signal peptide mutations | Intracellular accumulation | | **7. Cross-linking** | Lysyl oxidase converts lysine → allysine | Lysyl oxidase deficiency (Ehlers-Danlos Type VI) | Defective cross-linking, not OI | **Clinical Pearl:** In OI Type I (the most common form, ~50% of cases), a single glycine-to-larger-amino-acid substitution in the Gly-X-Y repeat creates a structural defect that propagates through the entire triple helix, reducing its stability and tensile strength. This is different from quantitative defects (reduced collagen amount) seen in OI Type II. ### Why This Answer is Correct The COL1A1 mutation in this patient causes a **glycine substitution** in the Gly-X-Y repeat. Because glycine is uniquely small (only a hydrogen atom as its side chain), any larger amino acid substituted at this position creates a steric clash that: 1. Prevents proper triple helix winding 2. Introduces local kinks and distortions 3. Destabilizes the entire collagen molecule 4. Results in defective bone matrix and increased fracture risk **High-Yield:** This is the **most common molecular defect in OI Type I** (missense mutations causing Gly substitution). ### Why Each Distractor is Wrong See below. [cite:Robbins 10e Ch 3; Lehninger Principles of Biochemistry 8e Ch 5]